On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayMay 09, 2017 3:23 pm

ChineseInvestors.com, Inc. (CIIX) Aims to Excel in CBD Markets

For nearly two decades, ChineseInvestors.com (OTCQB: CIIX) has delivered a wide range of products, information, and services, including several subscription-based services, for the global Chinese speaking population. The specialized investment services company provides real-time market commentary, analysis, and education-related information in the Chinese language, as well as offering consultation, advertising, and public relations services. The company’s product diversity is a result of its growth-focused, long term quest for value-add opportunities. Not satisfied with a 100,000+ user base, a recognizable 18-year-old brand, and a target market in excess of two billion Chinese speaking people, ChineseInvestors.com recently executed a first-to-market milestone by…

Continue Reading

MondayMay 08, 2017 2:55 pm

ABcann Medicinals (TSXV: ABCN) Has Strong Start with Canadian TSX Venture Exchange Listing

Going public appears to be paying off for ABcann Medicals (TSXV: ABCN), since the medical cannabis grower launched its initial public offering (IPO) on the TSX Venture Exchange. Although the IPO was just launched on May 4 (http://nnw.fm/Lt5DO), its value took off, soaring over 26% on the first day and trading over 25% of the total volume on the exchange. ABcann is one of Canada’s major legal cannabis producers, and the public offers are set to provide even more investor benefits as the recreational marijuana market is now positioned for nationwide legalization. Raising capital was part of the company’s decision…

Continue Reading

MondayMay 08, 2017 12:55 pm

India Globalization Capital, Inc. (NYSE: IGC) Positioned to Lead in Phytocannabinoid Pharmaceuticals

A study recently highlighted by the American Epilepsy Society (AES) at its 70th annual meeting focused on the potential of cannabidiol (CBD), a derivative of the cannabis plant, as a promising treatment for reducing both the frequency and severity of seizures in children with drug resistant epilepsies (http://nnw.fm/u3xAh). According to the study, patients who received CBD treatment exhibited over 45 percent mean reduction in seizures, and researchers were outspoken in support of further research. Cannabidiol is the most abundant non-psychoactive cannabinoid found in the cannabis plant. Both anecdotal evidence and pre-clinical research have suggested that CBD may have a broad…

Continue Reading

FridayMay 05, 2017 2:37 pm

India Globalization Capital, Inc. (NYSE: IGC) Engages a Critical Point in Cannabis History

Cannabis is now legal medically or recreationally in 28 states in the U.S., and companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are developing revolutionary cannabinoid-based combination pharmaceutical therapies. Cannabis’ history doesn’t begin in the 1960s. Scientists have dated burned cannabis seeds found in Siberia to 3,000 B.C., and mummified psychoactive marijuana has been found in tombs of individuals buried around 2,500 B.C. Fast forward a few thousand years and add laws, regulations, and cultural stigma, and behold one of the most disputed substances. In the 1850s, recreational cannabis was considered fashionable in the U.S., and it was…

Continue Reading

ThursdayMay 04, 2017 12:27 pm

India Globalization Capital (NYSE: IGC) Strategically Staking Claims in the Medical Marijuana Markets

In a testament to its medical efficacy, 29 states and the District of Columbia have now legalized medical marijuana. This groundswell with state sanction and now widespread public acceptance has started a stampede of companies jockeying to profit from legalization. From the sale of oils and extracts to specialized cultivation, multiple companies are rushing into this new market hoping to cash in on surging demand. However, rushing in just might not be the right approach to making real money in this sector. There’s an old adage that says the way to create real wealth is to find out where everyone…

Continue Reading

WednesdayMay 03, 2017 1:04 pm

ABcann Medicinals Could Join the Ranks of Canadian Licensed Marijuana Producers with Rising Valuations after IPO

All eyes are on ABcann Medicinals, Inc. as it prepares to go public. The company, which is already growing rapidly, wants to expand its footprint in Canada and take advantage of potential international opportunities. Additional production facilities are planned to meet the expected supply short fall in the Canadian market when marijuana for recreational use is legalized next year. With its state-of-the-art cultivation facilities and established patient-client care systems, ABcann has the infrastructure in place to profit from that billion-dollar Canadian marijuana market. With adult use of marijuana set for legalization by July 1, 2018, the Canadian marijuana market is…

Continue Reading

WednesdayMay 03, 2017 9:00 am

Paws Firmly Planted for Growth in Multibillion-Dollar Pet Health Market

CannabisNewsWire Editorial Coverage: Pets are the loyal, much-loved companions we humans can’t seem to live without, and when a beloved pet becomes ill, owners will generally do whatever it takes to restore these beloved companion animals to health. Various public companies are accomplishing the two-fold mission of improving the health of our four-footed friends while giving investors the opportunity to capitalize on a multibillion-dollar industry. India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), VCA, Inc. (NASDAQ: WOOF), PetMed Express, Inc. (NASDAQ: PETS), Blue Buffalo Pet Products, Inc. (NASDAQ: BUFF) and IDEXX Laboratories, Inc. (NASDAQ: IDXX) are just some of the…

Continue Reading

TuesdayMay 02, 2017 2:20 pm

ABcann Medicinals Set to Launch IPO This Week on TSXV

According to efficient markets theory, the chances of finding hundred-dollar bills lying on the ground are slim, at best. When one is dropped, some well-informed investor is quick to pick it up. However, with Abcann Medicinals set to launch its initial public offering (IPO) on the TSX Venture Exchange on May 4, the chances of finding those elusive hundreds have increased significantly. Investors will have an opportunity to take up shares in one of Canada’s major legal cannabis producers. With the marijuana recreational market in Canada set for legalization, the Abcann Medicinals IPO will level the playing field and offer…

Continue Reading

MondayMay 01, 2017 1:18 pm

ChineseInvestors.com, Inc. (CIIX) Set to Capitalize on Meteoric Growth of CBD Market

The chemical in marijuana that causes euphoria is delta-9 tetrahydrocannabinol, or THC. There are also over 100 other cannabinoid chemicals in the plant, including cannabidiol (CBD), one of the main active chemical compounds found in marijuana. CBD doesn’t make people high, isn’t intoxicating or addictive, and is gaining widespread acceptance as a natural and effective medicinal treatment for multiple disorders. Both anecdotal evidence and pre-clinical research have pointed to CBD as having a broad range of beneficial therapeutic uses, including anti-seizure, antioxidant, neuro-protective, anti-inflammatory, analgesic, anti-tumor, anti-anxiety, and anti-psychotic properties. CBD oil has already been legalized in all 50 U.S.…

Continue Reading

FridayApr 28, 2017 9:21 am

SinglePoint, Inc. (SING) is Poised for the Marijuana Tipping Point, Explains CEO in Recent Podcast

After ballots on November 8, 2016, seven more states, including California and Florida, will now permit the use of marijuana for either medical or recreational use. Currently, 29 states and the District of Columbia have passed initiatives or laws legalizing medical marijuana or regulating its adult use like alcohol or tobacco. Yet cannabis remains illegal under federal law, and banks are reluctant to open accounts for marijuana shops and dispensaries, leading to a variety of unfortunate results. It seems obvious that the current disharmony between state and federal law is not maintainable, and a tipping point when financial institutions open…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722